MAS insider files Form 144 for 2,431 restricted shares sale on NYSE

Rhea-AI Filing Summary

Masco Corporation (MAS) filed a Form 144 notifying a proposed sale of common stock. The filing lists 2,431 shares to be sold through Fidelity Brokerage Services LLC on the NYSE with an aggregate market value of $181,401.22 and reports approximately 209,363,636 shares outstanding. The shares were acquired by restricted stock vesting on 01/14/2024 (221 shares), 02/25/2024 (1,136 shares) and 02/25/2025 (1,074 shares). The filer states there were no securities sold in the past three months for the account and affirms they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Transparent disclosure of broker, share count, aggregate market value, approximate sale date and outstanding shares
• Acquisition history provided showing shares arose from restricted stock vesting on 01/14/2024, 02/25/2024 and 02/25/2025
• No sales in prior three months reported for the account, simplifying aggregation concerns

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Routine insider notice for a small proposed sale, properly documented under Rule 144.

The filing documents a proposed sale of 2,431 Masco common shares via a registered broker, including acquisition dates and that the shares resulted from restricted stock vesting. It includes the broker name, estimated sale date and aggregate market value, and explicitly reports no sales in the prior three months. From a compliance perspective this meets Rule 144 disclosure norms and the signer attests to absence of material nonpublic information. No indications of complex payment arrangements or aggregated prior sales are present.

Equity Research Analyst

TL;DR: Insider sale size is immaterial relative to outstanding shares; filing provides clear transaction history.

The proposed sale represents a very small fraction of total outstanding shares (2,431 of 209,363,636). Acquisition details show the position stems from recent restricted stock vesting across 2024 and 2025, indicating compensation-related shares rather than a large divestiture. The filing discloses approximate sale date and market value, enabling transparency but without material implications for capitalization or control.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2431	181401.22	209363636	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/14/2024	Restricted Stock Vesting	Issuer			221	01/14/2024	Compensation
Common	02/25/2024	Restricted Stock Vesting	Issuer			1136	02/25/2024	Compensation
Common	02/25/2025	Restricted Stock Vesting	Issuer			1074	02/25/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Masco (MAS) shares does the Form 144 propose to sell?

The filing proposes to sell 2,431 common shares.

What is the aggregate market value and approximate sale date listed for the MAS shares?

Aggregate market value is $181,401.22 and the approximate date of sale is 08/19/2025.

Through which broker will the MAS shares be sold and on which exchange?

The broker is Fidelity Brokerage Services LLC and the sale is to be on the NYSE.

How and when were the shares acquired for the proposed sale?

All shares were acquired via restricted stock vesting on 01/14/2024 (221 shares), 02/25/2024 (1,136 shares) and 02/25/2025 (1,074 shares).

Were any MAS securities sold in the past three months by the account?

The filing reports Nothing to Report for securities sold during the past three months.

Does the filer assert possession of any undisclosed material information about Masco?

By signing the notice the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.